Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Dec 22;46(48):5222-5233.
doi: 10.1093/eurheartj/ehaf605.

Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure

Nerea Mora-Ayestarán  1   2   3 , Juan Pablo Ochoa  4 , Cristina Gómez-González  2   3   5   6   7 , Marina Navarro-Peñalver  2   3   8 , María Gallego-Delgado  2   9   10 , José M Larrañaga-Moreira  11 , Ainhoa Robles-Mezcua  2   12   13 , María Teresa Basurte-Elorz  14   15 , Jose Fernando Rodriguez-Palomares  2   3   16   17 , Vicente Climent-Paya  18   19 , Juan Jiménez-Jaímez  20 , Maria Victoria Mogollón-Jiménez  21 , Pablo Elpidio García-Granja  2   22 , Ana García-Álvarez  2   4   23 , María Luisa Peña-Peña  3   24 , María Alvarez Barredo  2   25 , Tomas Ripoll-Vera  26 , Julián Palomino-Doza  2   27 , Antoni Bayes-Genis  2   28 , Coloma Tirón  2   29   30 , Ana Isabel Fernández  2   3   5   6 , María Sabater-Molina  2   3   8 , Inés Toranzo  2   9   10 , María G Crespo-Leiro  2   31 , Victoria Doncel-Abad  12   13 , Gemma Lacuey-Lecumberri  14   15 , Javier Limeres-Freire  2   3   16   17 , Maria I García-Álvarez  18   19 , Eva Cabrera-Borrego  20 , Zineb Kounka-Ait El Maalem  21 , Silvia Vilches  2   3   5   6   7 , Esther González-López  1   2   3   4 , Eduardo Villacorta  2   9   10 , José M García-Pinilla  2   12   13 , Roberto Barriales-Villa  2   11 , Juan Ramón Gimeno-Blanes  2   3   8 , Pablo Garcia-Pavia  1   2   3   4   32 , Fernando Domínguez  1   2   3   4
Affiliations
Multicenter Study

Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure

Nerea Mora-Ayestarán et al. Eur Heart J. .

Abstract

Background and aims: Certain genetic forms of dilated cardiomyopathy (DCM) entail a higher arrhythmic risk. It is unknown whether DCM patients with high-risk arrhythmic genotypes also develop more advanced heart failure (AHF) complications. AHF events were studied according to DCM genotype.

Methods: Clinical data from 1203 genotyped DCM patients were collected from 19 Spanish centres. Patients were classified into high-risk arrhythmic genotypes (LMNA, FLNC, desmosomal genes, PLN, TMEM43, RBM20), TTN, other genes, and genotype negative (Gen-). The primary endpoint was a composite of AHF events (ventricular assist device implantation, heart transplant, and AHF-related mortality). The secondary endpoint was a combination of malignant ventricular arrhythmias (MVA).

Results: A DCM-causing variant was identified in a high-risk arrhythmic gene in 185 patients (15.4%), 193 (16.0%) had variants in TTN, 134 (11.1%) in other genes, and 691 (57.4%) were Gen-. After a median follow-up of 5.7 years (interquartile range 2.9-9.1 years), AHF events occurred in 45 (24.3%) patients in the high-risk arrhythmic group, while in 25 (18.7%), 25 (13.0%), and 70 (10.1%) patients with other genotypes, TTN, and Gen-, respectively (hazard ratio 1.85, 95% confidence interval 1.31-2.61 for high-risk arrhythmic genes compared with other groups). MVA occurred in 55 patients (29.7%) (hazard ratio 2.52, 95% confidence interval 1.81-3.51 for high-risk genotypes vs other groups). High-risk arrhythmic genotype was the main independent predictor of AHF in multivariate analysis. High-risk arrhythmic genotype and late gadolinium enhancement were independent predictors of MVA.

Conclusions: Patients with high-risk arrhythmic genotypes also experience more AHF events, supporting a differential therapeutic approach in this group of patients beyond sudden death prevention.

Keywords: Dilated cardiomyopathy; Genes; Heart failure; Prognosis; Sudden cardiac death.

PubMed Disclaimer

Figures

Structured Graphical Abstract
Structured Graphical Abstract
Figure 1
Figure 1
Advanced heart failure and malignant ventricular arrhythmia according to genetic subgroup
Figure 2
Figure 2
Advanced heart failure according to genotype and LVEF ≤35% or >35
Figure 3
Figure 3
Malignant ventricular arrhythmia according to genotype and LVEF ≤35% or >35%
See this image and copyright information in PMC

References

    1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270–6. 10.1093/eurheartj/ehm342 - DOI - PubMed
    1. McKenna WJ, Judge DP. Epidemiology of the inherited cardiomyopathies. Nat Rev Cardiol 2021;18:22–36. 10.1038/s41569-020-0428-2 - DOI - PubMed
    1. Fatkin D, Huttner IG, Kovacic JC, Seidman JG, Seidman CE. Precision medicine in the management of dilated cardiomyopathy. J Am Coll Cardiol 2019;74:2921–38. 10.1016/j.jacc.2019.10.011 - DOI - PubMed
    1. Escobar-Lopez L, Ochoa JP, Mirelis JG, Espinosa MÁ, Navarro M, Gallego-Delgado M, et al. Association of genetic variants with outcomes in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol 2021;78:1682–99. 10.1016/j.jacc.2021.08.039 - DOI - PubMed
    1. Jansweijer JA, Nieuwhof K, Russo F, Hoorntje ET, Jongbloed JD, Lekanne Deprez RH, et al. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy. Eur J Heart Fail 2017;19:512–21. 10.1002/ejhf.673 - DOI - PubMed

Publication types